Schedule 13G ownership disclosure

Relmada Therapeutics Inc

Security class unavailable · CUSIP: 75955J402

Event date: 2020-06-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,255,857
Percent of class
8.2600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493215-20-000002
Form type
SC 13G
Filer
RELMADA THERAPEUTICS, INC.
CIK
CIK 1553643
Filed
Jun 11, 2020
Reporting period
Jun 01, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub